NEWS
KalVista Presents Data at WSAAI 60th Annual Scientific Session
KalVista Pharmaceuticals, Inc. presents three posters at the Western Society of Allergy, Asthma & Immunology 60th Annual Scientific Session in Kona, the United States. The first highlights that KONFIDENT-S (NCT05505916) is a prospective trial to [...]
FDA Approves TAKHZYRO® to Prevent HAE Attacks in Children 2 Years of Age and Older
The U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the expanded use of Takeda's TAKHZYRO® (lanadelumab-flyo) for prophylaxis to prevent attacks of HAE in pediatric patients 2 to <12 [...]
BioCryst enrolling first patient in pediatric trial
BioCryst Pharmaceuticals, Inc. announces the enrollment of the first patient in the pivotal APeX-P trial evaluating oral, once-daily ORLADEYO® (berotralstat) in pediatric HAE patients who are 2 to <12 years of age. “Today’s announcement marks [...]
BioCryst commercializes ORLADEYO in Central and Eastern Europe
BioCryst Pharmaceuticals, Inc. enters into a collaboration with Swixx BioPharma AG to commercialize ORLADEYO® (berotralstat) in Central and Eastern Europe. “We continue to build partnerships with companies that have deep expertise in commercializing rare disease [...]
ADARx doses first cohort in clinical study
ADARx Pharmaceuticals, Inc. announces the dosing of the first cohort in a Phase 1 clinical study of ADX-324 for the treatment of HAE. “We are very excited to be advancing our first candidate that utilizes our proprietary PLR™ delivery [...]
News from the UK
From HAE UK Well, what a busy few months it has been for HAE UK! As CEO, Angela Metcalfe was delighted to attend the 2022 HAEi Global Leadership Workshop in Frankfurt, Germany, at the [...]
News from Israel
Israeli HAE patients have gained access to Orladeyo, so with Ruconest, Berinert, and Firazyr already on the market, there are now four modern HAE medications in the country. >> See more about HAE in Israel [...]
News from Turkey
From President Gökben Yurdakul, HAE Turkey In response to the challenges posed by the COVID-19 pandemic, HAE Turkey took action to provide support for patients and their families. We held information meetings with doctors in [...]
News from Canada
From HAE Canada As the season ends, we must start with the most impactful event from fall 2022: the 2022 HAEi Global Leadership Workshop in Frankfurt, Germany. We’d like to deeply thank the HAEi [...]
News from Ireland
Any people with HAE in Ireland who are interested in participating in a clinical trial or receiving news on new treatments, please get in touch with HAEi Regional Patient Advocate Maria Ferron at gro.ieah@norref.m. [...]
News from Spain
From HAE Spain (AEDAF) HAE Spain (AEDAF) Camino Walk 2023: AEDAF is pleased to announce that it will be organizing another hae day :-) event on the Camino de Santiago: the HAE Spain (AEDAF) [...]
News from USA
From US HAEA 2022 HAEA Year in Review: Throughout 2022, the HAEA has continued to provide our 8,000 members with programs, services, and activities that engage and unite our community, and help people maintain [...]
News from North Macedonia
On 4 November 2022, HAE Macedonia organized a meeting for North Macedonian patients in Skopje. The meeting was attended by 18 patients and caregivers and allowed patients to see each other for the first [...]
News from Australia and New Zealand
From CEO Fiona Wardman, HAE Australasia HAE Australasia received ethics approval to run the HAE pharmaco and socioeconomic/quality of life survey. This critical survey is for patients and their family members in Australia and [...]
News from Colombia
“Mi vida con AEH” (“My life with HAE”) is a new podcast from HAE Colombia which seeks to create awareness through the stories and experiences of the members. The aim is to motivate, help [...]
News from Singapore
From HAE Singapore: The first patient meeting has taken place in Singapore. Patients have connected and there are plans in place to advocate as a group and get things moving here. [...]
News from Russia
From President Elena Bezbozhnaya, HAE Russia Over the past six months, HAE Russia has hosted various highlights, face-to-face meetings, and online webinars, with adults and children involved from all over the country. Over the [...]
News from Switzerland
From Vice President Ernst Greber, HAE Switzerland Impressions from the 2022 HAEi Global Leadership Workshop in Frankfurt, Germany: We were represented by three board members The event was excellently organized The lectures were very [...]
News from Japan
From President Beverley Yamamoto, HAE Japan We have seen great improvement in the treatment environment in Japan over the last two years, and in September the third long term prophylactic treatment was approved by [...]
Intellia’s in vivo genome editing candidate awarded Innovation Passport
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has awarded the Innovation Passport for Intellia Therapeutics, Inc.'s NTLA-2002, an in vivo genome editing candidate being developed for the treatment of HAE. The Innovation Passport [...]
BioCryst more than doubles first-year ORLADEYO sales
At the presentation of the preliminary, unaudited ORLADEYO® (berotralstat) net revenue for the fourth quarter and full year 2022, Jon Stonehouse, President and CEO of BioCryst Pharmaceuticals, Inc., says: “In our second year on the [...]
Business updates and company highlights from Pharvaris
Pharvaris provides business updates and company highlights: Meeting minutes from Type A meeting with U.S. Food and Drug Administration (FDA) received. Pharvaris will conduct a 26-week rodent toxicology study to resolve the clinical holds in [...]
Intellia moving closer to setting new standard of care
Intellia Therapeutics, Inc. announces its strategic priorities for the upcoming two years as the Company enters its next phase of pipeline execution and platform innovation. Among the 2023-2024 Strategic Priorities are to initiate global pivotal [...]
hae day :-) 2023 is around the corner
If it isn’t in your diary already, mark 16 May 2023 for hae day :-) This is our annual celebration of the HAE community and our focus on awareness-raising efforts. We are already thinking [...]
Acare Network Grows to 75 Centers
The global network of Angioedema Centers of Reference and Excellence (ACARE) – a joint venture between the Global Allergy and Asthma European Network GA2LEN and HAEi – continues to grow! “We now have 75 [...]
Stay Tuned
Be the first to know what’s going on in the world of HAE
Upcoming events
Mar 17, 2023 - Mar 19, 2023
HAEi Regional Conference APAC 2023
Apr 22, 2023
HAE Spain (AEDAF) 25th General Assembly & Annual Meeting
May 4, 2023 - May 7, 2023
13th C1-inhibitor Deficiency & Angioedema Workshop
May 13, 2023 - May 17, 2023
HAE Spain (AEDAF) Camino Walk 2023
HAE related topics that might interest you
Global Perspectives
Magazine with timely information on the issues, activities, and events that are relevant to the global HAE community
HAEi Advocacy Academy
Courses, advocacy training, and tools to support people living with HAE and becoming an HAE advocate
HAEi Connect Member database
Free, secure online membership database and communications platform for HAEi’s member organizations
HAE Companion app
Access to HAEi’s emergency card in many languages and ACARE Centers, HAE knowledgeable hospitals and physicians
Stay tuned – sign up for our newsletter
BE THE FIRST TO KNOW ABOUT HAE NEWS, TREATMENTS, EVENTS AND RELATED TOPICS
